A new drug shows potential benefits in the recovery of patients after a heart attack
Researchers from the Cardiac Regeneration and Heart Failure Research Group (ICREC) at the Germans Trias i Pujol Research Institute (IGTP) and the Heart Institute of the Germans Trias Hospital (iCor) have found beneficial effects of the novel drug Sacubitril/Valsartan in the management of myocardial infarction (MI).
![](/media/upload/gif/10_Heart Disease Research (2)_1715606541.jpg)